ICLIT significantly improved the symptoms of most allergic rhinoconjunctivitis children
allergic symptoms
Short-term efficacy and long-term efficacy were observed for allergic symptoms at the first and third year after treatment only in ICLIT group. After undergoing ICLIT, 23 patients had significant symptom improvement (p < 0.0001) in both short-term (1 year after treatment) and long-term (3 year after treatment) (Symptom changes after ICLIT treatment. Compared with baseline, 